Farxiga lawsuits claim Farxiga and its sister drug, Xigduo XR, may cause diabetic ketoacidosis and kidney injury. They accuse Bristol-Myers Squibb Co. and AstraZeneca of failing to adequately test the drugs and warn of their risks. As of May 2018, a total of 50 Farxiga lawsuits had been consolidated in federal court in the Southern District of New York.
If you or a loved one have suffered from ketoacidosis or kidney injury after taking Farxiga, you may be eligible for compensation.
*Update: In May 2018, lawyers on both sides of Farxiga lawsuits were deciding which of the 49 pending federal cases should go to trial first. Drugwatch’s legal partners are currently accepting new cases.
As of May 2018, a total of 60 Farxiga lawsuits had been filed in federal court against Bristol-Myers Squibb Co. and AstraZeneca. About 50 remained pending.
Injured patients from across the U.S. filed the lawsuits. They blame Farxiga and its sister drug, Xigduo XR, for their diabetic ketoacidosis, kidney injury and infections.
In April 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated the lawsuits into a multidistrict litigation (MDL) in a New York federal court.
MDLs help speed up the legal process when many lawsuits accuse the same defendants of similar wrongdoing.
Lawyers on both sides of the MDL are selecting Farxiga cases they would like to go to trial first. These trials are known as bellwether trials.
Bellwether trials act as “test trials” to see how the growing number of lawsuits might be decided. Their outcomes can influence large-scale settlement talks.
Farxiga and Xigduo XR are a part of a larger class of Type 2 diabetes medications called SGLT2 inhibitors. This class of drugs includes Invokana, a drug that also causes patients to suffer amputations. The first Invokana amputation trial is set for September 2018.
People suing over Farxiga blame the drug for causing injuries that led to dialysis, hospitalization and death.
Farxiga is the brand name for the drug dapagliflozin. Xigduo XR is another brand of SGLT2 inhibitor named alongside Farxiga in lawsuits.
Xigduo XR contains a combination of dapagliflozin and metformin.
Invokana is another Type 2 diabetes drug. It is named in its own separate multidistrict litigation (MDL).
Farxiga lawsuits question the development, manufacture, testing, regulatory history, promotion and labeling of Farxiga.
They say the drug’s makers were negligent, reckless and careless in their handling of Farxiga.
“Defendants did not adequately and sufficiently warn consumers… or the medical community of the severity of such risks.”
If you suffer an injury after taking Farxiga, you may have a claim to recover money for damages.
A jury verdict or settlement can help restore a person to his or her situation before the injury occurred.
A qualified lawyer can assess whether you have a case and determine what types of damages you may qualify for. Products liability lawyers specialize in this area of law.
Statutes of limitations are predetermined time periods for bringing lawsuits.
They are designed to prevent fraudulent claims or claims that have become stale or out-of-date.
When too much time passes, evidence may be obscured and recall of events may be poor or inaccurate. It also can be harder to find available key witnesses.
A qualified product liability lawyer can answer questions related to your specific case and deadlines for filing a personal injury claim.
This discussion should take place as soon as you are aware of an injury resulting from Farxiga to avoid missing out on a viable claim.
There have been no publicized Farxiga settlements to date. The Farxiga multidistrict litigation is still in the early stages. Forty-nine cases remained pending before a New York federal judge in April 2018.
As more plaintiffs file claims, the drug’s manufacturers may begin to negotiate settlements to avoid multiple trials.
No cases have progressed to trial yet. So, there have been no jury verdicts related to Farxiga injury claims.
There are currently no publicized class action lawsuits over Farxiga. Instead, a judicial panel consolidated multiple cases into multidistrict litigation (MDL).
MDLs are like class actions barring one key difference. A class action is a single suit with many plaintiffs. MDLs involve many lawsuits moved to a single court and managed by the same judge.
Please seek the advice of a medical professional before making health care decisions.
Calling this number connects you with Wilson and Peterson, LLP or one of its trusted legal partners. A law firm representative will review your case for free.
Wilson and Peterson, LLP funds Drugwatch because it supports the organization’s mission to keep people safe from dangerous drugs and medical devices.(888) 653-9745